Top compounds associated with response to NECAB2


Feature Type Standardized
Nominal ANOVA
mRNA TAK-715 GDSC1000 pan-cancer AAC -0.0076 0.8
mRNA neopeltolide CTRPv2 pan-cancer AAC -0.017 0.8
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.0082 0.8
mRNA Topotecan FIMM pan-cancer AAC -0.025 0.8
mRNA IOX2 GDSC1000 pan-cancer AAC -0.0078 0.8
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.008 0.8
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0082 0.8
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.011 0.8
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.0084 0.8
mRNA itraconazole CTRPv2 pan-cancer AAC 0.0088 0.8
Download CSV